rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
10
|
pubmed:dateCreated |
2007-5-21
|
pubmed:abstractText |
Anderson-Fabry disease (AFD) is an uncommon X-linked disorder caused by deficient activity of the lysosomal enzyme alpha-galactosidase A. The Fabry Outcome Survey is a European database designed to monitor the long-term efficacy and safety of enzyme replacement therapy (ERT) with agalsidase alfa. The aim of this study was to determine the prevalence and characteristics of cardiac disease in AFD patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0195-668X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1228-35
|
pubmed:meshHeading |
pubmed-meshheading:17483538-Adult,
pubmed-meshheading:17483538-Dyspnea,
pubmed-meshheading:17483538-Echocardiography,
pubmed-meshheading:17483538-Europe,
pubmed-meshheading:17483538-Fabry Disease,
pubmed-meshheading:17483538-Female,
pubmed-meshheading:17483538-Glomerular Filtration Rate,
pubmed-meshheading:17483538-Heart Diseases,
pubmed-meshheading:17483538-Humans,
pubmed-meshheading:17483538-Hypertrophy, Left Ventricular,
pubmed-meshheading:17483538-Isoenzymes,
pubmed-meshheading:17483538-Male,
pubmed-meshheading:17483538-Middle Aged,
pubmed-meshheading:17483538-Prevalence,
pubmed-meshheading:17483538-Risk Factors,
pubmed-meshheading:17483538-Syncope,
pubmed-meshheading:17483538-Treatment Outcome,
pubmed-meshheading:17483538-alpha-Galactosidase
|
pubmed:year |
2007
|
pubmed:articleTitle |
Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey.
|
pubmed:affiliation |
Second Department of Internal Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic. alinh@lf1.cuni.cz
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|